SpectRx, Inc. is a medical technology company focused on insulin delivery and glucose monitoring products for the diabetes management market and biophotonic devices and technology for the non-invasive cancer diagnostics market. Historically, the Company's technology has been primarily based upon biophotonic technology, which it defines as the use of light and other forms of energy to access the human body to diagnose and monitor disease. SpectRx added insulin delivery to its technology base with the purchase of Sterling Medivations, Inc., now doing business as SimpleChoice. During the year ended December 31, 2003, the Company's technology, including products in development, includes methods of delivering insulin to people with diabetes with the SimpleChoice product line. It also includes methods of sampling interstitial fluid using laser energy to create micropores for improved glucose and alcohol monitoring and biophotonics technology for the non-invasive detection of cancers.